Published in Br J Cancer on March 31, 2016
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Test of the National Death Index. Am J Epidemiol (1984) 8.46
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93
Applying Cox regression to competing risks. Biometrics (1995) 6.32
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest (2008) 5.26
Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer (2001) 4.61
Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37
The nurses' health study. Am J Nurs (1978) 3.00
Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res (1994) 2.84
TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov (2010) 2.17
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med (2007) 2.05
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol (1995) 1.74
Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology (2010) 1.56
Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer (2000) 1.52
A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care (2005) 1.34
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer (2006) 1.16
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer (2013) 1.15
Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol (2013) 1.05
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis (2007) 1.01
Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. J Biol Chem (2000) 0.97
Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev (2013) 0.95
Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Eur Cytokine Netw (2009) 0.94
Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer (1997) 0.91
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma. Clin Cancer Res (2012) 0.89
Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells. Mol Cancer Res (2011) 0.83
Potential biomarker for aspirin use in colorectal cancer therapy. Nat Rev Clin Oncol (2012) 0.82
TNFα-activated stromal COX-2 signalling promotes proliferative and invasive potential of colon cancer epithelial cells. Cell Prolif (2013) 0.81
Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis. Biomed Pharmacother (2013) 0.79
Aspirin use after diagnosis improves survival in older adults with colon cancer. J Am Geriatr Soc (2013) 0.78